The store will not work correctly when cookies are disabled.
4'-fluoro-6-(3-hydroxypropyl)biphenyl-3-carboxamide
ID: ALA4569810
PubChem CID: 122623278
Max Phase: Preclinical
Molecular Formula: C16H16FNO2
Molecular Weight: 273.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccc(CCCO)c(-c2ccc(F)cc2)c1
Standard InChI: InChI=1S/C16H16FNO2/c17-14-7-5-12(6-8-14)15-10-13(16(18)20)4-3-11(15)2-1-9-19/h3-8,10,19H,1-2,9H2,(H2,18,20)
Standard InChI Key: QDVRUQCYYCVULV-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
8.4759 -5.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4748 -6.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1828 -6.9942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8925 -6.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8896 -5.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1810 -5.3568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5958 -5.3508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3023 -5.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0080 -5.3492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0054 -4.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2911 -4.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5884 -4.5383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7110 -4.1189 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.1826 -7.8114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4748 -8.2198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8902 -8.2202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1786 -4.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8851 -4.1289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8826 -3.3118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5891 -2.9011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
10 13 1 0
3 14 1 0
14 15 2 0
14 16 1 0
6 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.31 | Molecular Weight (Monoisotopic): 273.1165 | AlogP: 2.52 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.32 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.58 | CX LogD: 2.58 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.88 | Np Likeness Score: -0.34 |
References
1. (2018) Substituted n-([1,1''-biphenyl]-3-yl)-[1,1''-biphenyl]-3-carboxamide analogs as inhibitors for beta-catenin/b-cell lymphoma 9 interactions, |